Russia starts large-scale trials of third COVID-19 vaccine

Russia starts large-scale trials of third COVID-19 vaccine
  • Clock-gray 13:36
  • calendar-gray 25 March 2021

Russia’s Chumakov Center has started phase three trials of CoviVac, Russia’s third vaccine against COVID-19, the Interfax news agency cited a government minister as saying on Thursday, APA reports citing Reuters.

The most well known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two others, EpiVacCorona and CoviVac.

Farid Akbarov

Other news